nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—Cyclandelate—CES1—obesity	0.0106	1	CrCbGaD
Scopolamine—CHRM3—muscle of abdomen—obesity	0.00502	0.398	CbGeAlD
Scopolamine—Hallucination—Cimetidine—obesity	0.00249	0.00461	CcSEcCtD
Scopolamine—Tremor—Phentermine—obesity	0.00247	0.00456	CcSEcCtD
Scopolamine—Dry eye—Sibutramine—obesity	0.00246	0.00455	CcSEcCtD
Scopolamine—Agitation—Phentermine—obesity	0.00242	0.00448	CcSEcCtD
Scopolamine—Arrhythmia—Diethylpropion—obesity	0.00235	0.00435	CcSEcCtD
Scopolamine—Erythema—Diethylpropion—obesity	0.00229	0.00424	CcSEcCtD
Scopolamine—Confusional state—Phenylpropanolamine—obesity	0.00227	0.00419	CcSEcCtD
Scopolamine—Constipation—Phendimetrazine—obesity	0.00225	0.00416	CcSEcCtD
Scopolamine—Depressed level of consciousness—Bupropion—obesity	0.00224	0.00415	CcSEcCtD
Scopolamine—Eczema—Orlistat—obesity	0.00222	0.00411	CcSEcCtD
Scopolamine—Dry mouth—Phentermine—obesity	0.00219	0.00406	CcSEcCtD
Scopolamine—Redness—Topiramate—obesity	0.00219	0.00406	CcSEcCtD
Scopolamine—Tachycardia—Phenylpropanolamine—obesity	0.00219	0.00406	CcSEcCtD
Scopolamine—Photophobia—Bupropion—obesity	0.00218	0.00403	CcSEcCtD
Scopolamine—Paranoia—Topiramate—obesity	0.00217	0.00402	CcSEcCtD
Scopolamine—Vision blurred—Diethylpropion—obesity	0.00216	0.00399	CcSEcCtD
Scopolamine—Eczema—Sibutramine—obesity	0.00215	0.00398	CcSEcCtD
Scopolamine—Oedema—Phentermine—obesity	0.00215	0.00398	CcSEcCtD
Scopolamine—Tremor—Diethylpropion—obesity	0.00215	0.00397	CcSEcCtD
Scopolamine—Dry eye—Bupropion—obesity	0.00215	0.00397	CcSEcCtD
Scopolamine—SI—digestive system—obesity	0.00211	0.167	CbGeAlD
Scopolamine—Agitation—Diethylpropion—obesity	0.00211	0.0039	CcSEcCtD
Scopolamine—Thirst—Orlistat—obesity	0.0021	0.00389	CcSEcCtD
Scopolamine—Hypotension—Phenylpropanolamine—obesity	0.0021	0.00388	CcSEcCtD
Scopolamine—Tachycardia—Phentermine—obesity	0.0021	0.00388	CcSEcCtD
Scopolamine—Abdominal pain—Phendimetrazine—obesity	0.00208	0.00385	CcSEcCtD
Scopolamine—Amnesia—Sibutramine—obesity	0.00206	0.00381	CcSEcCtD
Scopolamine—Thirst—Sibutramine—obesity	0.00203	0.00376	CcSEcCtD
Scopolamine—Agitation—Cimetidine—obesity	0.002	0.00371	CcSEcCtD
Scopolamine—Somnolence—Phenylpropanolamine—obesity	0.002	0.00369	CcSEcCtD
Scopolamine—Dizziness—Methamphetamine—obesity	0.00198	0.00366	CcSEcCtD
Scopolamine—Constipation—Phenylpropanolamine—obesity	0.00192	0.00355	CcSEcCtD
Scopolamine—Amblyopia—Topiramate—obesity	0.00192	0.00355	CcSEcCtD
Scopolamine—Dizziness—Benzphetamine—obesity	0.00191	0.00353	CcSEcCtD
Scopolamine—Dry mouth—Diethylpropion—obesity	0.00191	0.00353	CcSEcCtD
Scopolamine—Psychotic disorder—Sibutramine—obesity	0.00189	0.00349	CcSEcCtD
Scopolamine—Disorientation—Bupropion—obesity	0.00189	0.00349	CcSEcCtD
Scopolamine—Eczema—Bupropion—obesity	0.00188	0.00347	CcSEcCtD
Scopolamine—Headache—Methamphetamine—obesity	0.00187	0.00347	CcSEcCtD
Scopolamine—Mydriasis—Topiramate—obesity	0.00186	0.00343	CcSEcCtD
Scopolamine—Fatigue—Phentermine—obesity	0.00185	0.00343	CcSEcCtD
Scopolamine—Feeling abnormal—Phenylpropanolamine—obesity	0.00185	0.00342	CcSEcCtD
Scopolamine—Urinary retention—Sibutramine—obesity	0.00184	0.0034	CcSEcCtD
Scopolamine—Constipation—Phentermine—obesity	0.00184	0.0034	CcSEcCtD
Scopolamine—Dry skin—Orlistat—obesity	0.00183	0.00339	CcSEcCtD
Scopolamine—Tachycardia—Diethylpropion—obesity	0.00183	0.00338	CcSEcCtD
Scopolamine—Hyperhidrosis—Diethylpropion—obesity	0.00181	0.00334	CcSEcCtD
Scopolamine—Headache—Benzphetamine—obesity	0.00181	0.00334	CcSEcCtD
Scopolamine—Amnesia—Bupropion—obesity	0.0018	0.00332	CcSEcCtD
Scopolamine—Confusional state—Cimetidine—obesity	0.00179	0.00332	CcSEcCtD
Scopolamine—Dry skin—Sibutramine—obesity	0.00177	0.00328	CcSEcCtD
Scopolamine—Thirst—Bupropion—obesity	0.00177	0.00328	CcSEcCtD
Scopolamine—Dizziness—Phendimetrazine—obesity	0.00174	0.00322	CcSEcCtD
Scopolamine—Tachycardia—Cimetidine—obesity	0.00174	0.00321	CcSEcCtD
Scopolamine—Speech disorder—Topiramate—obesity	0.00172	0.00318	CcSEcCtD
Scopolamine—Nausea—Benzphetamine—obesity	0.00171	0.00317	CcSEcCtD
Scopolamine—Disturbance in attention—Topiramate—obesity	0.00171	0.00316	CcSEcCtD
Scopolamine—Muscular weakness—Sibutramine—obesity	0.00171	0.00316	CcSEcCtD
Scopolamine—Abdominal pain—Phentermine—obesity	0.0017	0.00314	CcSEcCtD
Scopolamine—Dysphagia—Sibutramine—obesity	0.00167	0.00309	CcSEcCtD
Scopolamine—Somnolence—Diethylpropion—obesity	0.00166	0.00308	CcSEcCtD
Scopolamine—Headache—Phendimetrazine—obesity	0.00165	0.00305	CcSEcCtD
Scopolamine—Psychotic disorder—Bupropion—obesity	0.00165	0.00305	CcSEcCtD
Scopolamine—Irritability—Bupropion—obesity	0.00161	0.00298	CcSEcCtD
Scopolamine—Urinary retention—Bupropion—obesity	0.0016	0.00297	CcSEcCtD
Scopolamine—Constipation—Diethylpropion—obesity	0.0016	0.00296	CcSEcCtD
Scopolamine—Somnolence—Cimetidine—obesity	0.00158	0.00293	CcSEcCtD
Scopolamine—Dysuria—Sibutramine—obesity	0.00156	0.00289	CcSEcCtD
Scopolamine—Nausea—Phendimetrazine—obesity	0.00156	0.00289	CcSEcCtD
Scopolamine—Dry skin—Bupropion—obesity	0.00155	0.00286	CcSEcCtD
Scopolamine—Asthenia—Phentermine—obesity	0.00154	0.00285	CcSEcCtD
Scopolamine—Feeling abnormal—Diethylpropion—obesity	0.00154	0.00285	CcSEcCtD
Scopolamine—Fatigue—Cimetidine—obesity	0.00153	0.00284	CcSEcCtD
Scopolamine—Constipation—Cimetidine—obesity	0.00152	0.00281	CcSEcCtD
Scopolamine—Muscular weakness—Bupropion—obesity	0.00149	0.00275	CcSEcCtD
Scopolamine—Dizziness—Phenylpropanolamine—obesity	0.00149	0.00275	CcSEcCtD
Scopolamine—Feeling abnormal—Cimetidine—obesity	0.00147	0.00271	CcSEcCtD
Scopolamine—Dysphagia—Bupropion—obesity	0.00146	0.0027	CcSEcCtD
Scopolamine—Conjunctivitis—Sibutramine—obesity	0.00145	0.00268	CcSEcCtD
Scopolamine—Depressed level of consciousness—Topiramate—obesity	0.00143	0.00264	CcSEcCtD
Scopolamine—Sweating—Sibutramine—obesity	0.00143	0.00264	CcSEcCtD
Scopolamine—Vomiting—Phenylpropanolamine—obesity	0.00143	0.00264	CcSEcCtD
Scopolamine—Dizziness—Phentermine—obesity	0.00142	0.00263	CcSEcCtD
Scopolamine—Rash—Phenylpropanolamine—obesity	0.00142	0.00262	CcSEcCtD
Scopolamine—Dermatitis—Phenylpropanolamine—obesity	0.00142	0.00262	CcSEcCtD
Scopolamine—Body temperature increased—Cimetidine—obesity	0.00141	0.0026	CcSEcCtD
Scopolamine—Photophobia—Topiramate—obesity	0.00139	0.00257	CcSEcCtD
Scopolamine—Pharyngitis—Orlistat—obesity	0.00137	0.00254	CcSEcCtD
Scopolamine—Dry eye—Topiramate—obesity	0.00137	0.00253	CcSEcCtD
Scopolamine—Vomiting—Phentermine—obesity	0.00137	0.00253	CcSEcCtD
Scopolamine—Urinary tract disorder—Orlistat—obesity	0.00137	0.00253	CcSEcCtD
Scopolamine—Dysuria—Bupropion—obesity	0.00136	0.00252	CcSEcCtD
Scopolamine—Bradycardia—Sibutramine—obesity	0.00136	0.00252	CcSEcCtD
Scopolamine—Urethral disorder—Orlistat—obesity	0.00136	0.00251	CcSEcCtD
Scopolamine—Rash—Phentermine—obesity	0.00136	0.00251	CcSEcCtD
Scopolamine—Dermatitis—Phentermine—obesity	0.00135	0.0025	CcSEcCtD
Scopolamine—Headache—Phentermine—obesity	0.00135	0.00249	CcSEcCtD
Scopolamine—Nausea—Phenylpropanolamine—obesity	0.00133	0.00247	CcSEcCtD
Scopolamine—Pharyngitis—Sibutramine—obesity	0.00133	0.00246	CcSEcCtD
Scopolamine—Visual impairment—Sibutramine—obesity	0.00129	0.00239	CcSEcCtD
Scopolamine—Nausea—Phentermine—obesity	0.00128	0.00236	CcSEcCtD
Scopolamine—Asthenia—Cimetidine—obesity	0.00128	0.00236	CcSEcCtD
Scopolamine—Conjunctivitis—Bupropion—obesity	0.00126	0.00234	CcSEcCtD
Scopolamine—Eye disorder—Sibutramine—obesity	0.00125	0.00231	CcSEcCtD
Scopolamine—Sweating—Bupropion—obesity	0.00125	0.0023	CcSEcCtD
Scopolamine—Dizziness—Diethylpropion—obesity	0.00124	0.00229	CcSEcCtD
Scopolamine—Mental disorder—Orlistat—obesity	0.00121	0.00224	CcSEcCtD
Scopolamine—Disorientation—Topiramate—obesity	0.0012	0.00222	CcSEcCtD
Scopolamine—Eczema—Topiramate—obesity	0.0012	0.00221	CcSEcCtD
Scopolamine—Arrhythmia—Sibutramine—obesity	0.0012	0.00221	CcSEcCtD
Scopolamine—Vomiting—Diethylpropion—obesity	0.00119	0.0022	CcSEcCtD
Scopolamine—Rash—Diethylpropion—obesity	0.00118	0.00218	CcSEcCtD
Scopolamine—Dermatitis—Diethylpropion—obesity	0.00118	0.00218	CcSEcCtD
Scopolamine—Dizziness—Cimetidine—obesity	0.00118	0.00218	CcSEcCtD
Scopolamine—Headache—Diethylpropion—obesity	0.00117	0.00217	CcSEcCtD
Scopolamine—Hallucination—Bupropion—obesity	0.00116	0.00215	CcSEcCtD
Scopolamine—Pharyngitis—Bupropion—obesity	0.00116	0.00214	CcSEcCtD
Scopolamine—Urinary tract disorder—Bupropion—obesity	0.00115	0.00213	CcSEcCtD
Scopolamine—Urethral disorder—Bupropion—obesity	0.00114	0.00212	CcSEcCtD
Scopolamine—Amnesia—Topiramate—obesity	0.00114	0.00212	CcSEcCtD
Scopolamine—Vision blurred—Orlistat—obesity	0.00113	0.0021	CcSEcCtD
Scopolamine—Vomiting—Cimetidine—obesity	0.00113	0.00209	CcSEcCtD
Scopolamine—Thirst—Topiramate—obesity	0.00113	0.00209	CcSEcCtD
Scopolamine—Visual impairment—Bupropion—obesity	0.00112	0.00208	CcSEcCtD
Scopolamine—Rash—Cimetidine—obesity	0.00112	0.00208	CcSEcCtD
Scopolamine—Dermatitis—Cimetidine—obesity	0.00112	0.00207	CcSEcCtD
Scopolamine—Headache—Cimetidine—obesity	0.00111	0.00206	CcSEcCtD
Scopolamine—Nausea—Diethylpropion—obesity	0.00111	0.00205	CcSEcCtD
Scopolamine—Vision blurred—Sibutramine—obesity	0.0011	0.00203	CcSEcCtD
Scopolamine—Tremor—Sibutramine—obesity	0.00109	0.00202	CcSEcCtD
Scopolamine—Eye disorder—Bupropion—obesity	0.00109	0.00202	CcSEcCtD
Scopolamine—Flushing—Bupropion—obesity	0.00108	0.002	CcSEcCtD
Scopolamine—Vertigo—Orlistat—obesity	0.00108	0.002	CcSEcCtD
Scopolamine—Agitation—Sibutramine—obesity	0.00107	0.00198	CcSEcCtD
Scopolamine—Nausea—Cimetidine—obesity	0.00106	0.00196	CcSEcCtD
Scopolamine—Psychotic disorder—Topiramate—obesity	0.00105	0.00194	CcSEcCtD
Scopolamine—Vertigo—Sibutramine—obesity	0.00105	0.00194	CcSEcCtD
Scopolamine—Arrhythmia—Bupropion—obesity	0.00104	0.00193	CcSEcCtD
Scopolamine—Irritability—Topiramate—obesity	0.00103	0.0019	CcSEcCtD
Scopolamine—Mental disorder—Bupropion—obesity	0.00102	0.00189	CcSEcCtD
Scopolamine—Urinary retention—Topiramate—obesity	0.00102	0.00189	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00102	0.00188	CcSEcCtD
Scopolamine—Dry mouth—Orlistat—obesity	0.001	0.00185	CcSEcCtD
Scopolamine—Oedema—Orlistat—obesity	0.000983	0.00182	CcSEcCtD
Scopolamine—Dry mouth—Sibutramine—obesity	0.00097	0.00179	CcSEcCtD
Scopolamine—Nervous system disorder—Orlistat—obesity	0.000964	0.00178	CcSEcCtD
Scopolamine—Confusional state—Sibutramine—obesity	0.000959	0.00177	CcSEcCtD
Scopolamine—Vision blurred—Bupropion—obesity	0.000957	0.00177	CcSEcCtD
Scopolamine—Skin disorder—Orlistat—obesity	0.000954	0.00177	CcSEcCtD
Scopolamine—Tremor—Bupropion—obesity	0.000952	0.00176	CcSEcCtD
Scopolamine—Oedema—Sibutramine—obesity	0.000951	0.00176	CcSEcCtD
Scopolamine—Hyperhidrosis—Orlistat—obesity	0.00095	0.00176	CcSEcCtD
Scopolamine—Muscular weakness—Topiramate—obesity	0.000948	0.00175	CcSEcCtD
Scopolamine—Agitation—Bupropion—obesity	0.000933	0.00173	CcSEcCtD
Scopolamine—Dysphagia—Topiramate—obesity	0.000929	0.00172	CcSEcCtD
Scopolamine—Tachycardia—Sibutramine—obesity	0.000928	0.00172	CcSEcCtD
Scopolamine—Skin disorder—Sibutramine—obesity	0.000924	0.00171	CcSEcCtD
Scopolamine—Hyperhidrosis—Sibutramine—obesity	0.000919	0.0017	CcSEcCtD
Scopolamine—Vertigo—Bupropion—obesity	0.000913	0.00169	CcSEcCtD
Scopolamine—Hypotension—Sibutramine—obesity	0.000889	0.00164	CcSEcCtD
Scopolamine—Dysuria—Topiramate—obesity	0.000869	0.00161	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000859	0.00159	CcSEcCtD
Scopolamine—Fatigue—Orlistat—obesity	0.000847	0.00157	CcSEcCtD
Scopolamine—Dry mouth—Bupropion—obesity	0.000846	0.00156	CcSEcCtD
Scopolamine—Somnolence—Sibutramine—obesity	0.000845	0.00156	CcSEcCtD
Scopolamine—Pain—Orlistat—obesity	0.00084	0.00155	CcSEcCtD
Scopolamine—Confusional state—Bupropion—obesity	0.000836	0.00155	CcSEcCtD
Scopolamine—Oedema—Bupropion—obesity	0.000829	0.00153	CcSEcCtD
Scopolamine—Pain—Sibutramine—obesity	0.000813	0.0015	CcSEcCtD
Scopolamine—Constipation—Sibutramine—obesity	0.000813	0.0015	CcSEcCtD
Scopolamine—Nervous system disorder—Bupropion—obesity	0.000813	0.0015	CcSEcCtD
Scopolamine—Feeling abnormal—Orlistat—obesity	0.00081	0.0015	CcSEcCtD
Scopolamine—Tachycardia—Bupropion—obesity	0.000809	0.0015	CcSEcCtD
Scopolamine—Skin disorder—Bupropion—obesity	0.000805	0.00149	CcSEcCtD
Scopolamine—Conjunctivitis—Topiramate—obesity	0.000805	0.00149	CcSEcCtD
Scopolamine—Hyperhidrosis—Bupropion—obesity	0.000801	0.00148	CcSEcCtD
Scopolamine—Feeling abnormal—Sibutramine—obesity	0.000784	0.00145	CcSEcCtD
Scopolamine—Body temperature increased—Orlistat—obesity	0.000777	0.00144	CcSEcCtD
Scopolamine—Abdominal pain—Orlistat—obesity	0.000777	0.00144	CcSEcCtD
Scopolamine—Hypotension—Bupropion—obesity	0.000775	0.00143	CcSEcCtD
Scopolamine—Bradycardia—Topiramate—obesity	0.000757	0.0014	CcSEcCtD
Scopolamine—Abdominal pain—Sibutramine—obesity	0.000752	0.00139	CcSEcCtD
Scopolamine—Body temperature increased—Sibutramine—obesity	0.000752	0.00139	CcSEcCtD
Scopolamine—Hallucination—Topiramate—obesity	0.00074	0.00137	CcSEcCtD
Scopolamine—Pharyngitis—Topiramate—obesity	0.000738	0.00136	CcSEcCtD
Scopolamine—Somnolence—Bupropion—obesity	0.000737	0.00136	CcSEcCtD
Scopolamine—Urinary tract disorder—Topiramate—obesity	0.000734	0.00136	CcSEcCtD
Scopolamine—Urethral disorder—Topiramate—obesity	0.000729	0.00135	CcSEcCtD
Scopolamine—Visual impairment—Topiramate—obesity	0.000716	0.00132	CcSEcCtD
Scopolamine—Fatigue—Bupropion—obesity	0.000715	0.00132	CcSEcCtD
Scopolamine—Constipation—Bupropion—obesity	0.000709	0.00131	CcSEcCtD
Scopolamine—Pain—Bupropion—obesity	0.000709	0.00131	CcSEcCtD
Scopolamine—Asthenia—Orlistat—obesity	0.000705	0.0013	CcSEcCtD
Scopolamine—Pruritus—Orlistat—obesity	0.000695	0.00129	CcSEcCtD
Scopolamine—Eye disorder—Topiramate—obesity	0.000695	0.00128	CcSEcCtD
Scopolamine—Flushing—Topiramate—obesity	0.00069	0.00128	CcSEcCtD
Scopolamine—Feeling abnormal—Bupropion—obesity	0.000683	0.00126	CcSEcCtD
Scopolamine—Asthenia—Sibutramine—obesity	0.000682	0.00126	CcSEcCtD
Scopolamine—Pruritus—Sibutramine—obesity	0.000673	0.00124	CcSEcCtD
Scopolamine—CHRM2—cardiovascular system—obesity	0.000672	0.0533	CbGeAlD
Scopolamine—Body temperature increased—Bupropion—obesity	0.000655	0.00121	CcSEcCtD
Scopolamine—Abdominal pain—Bupropion—obesity	0.000655	0.00121	CcSEcCtD
Scopolamine—Mental disorder—Topiramate—obesity	0.000651	0.0012	CcSEcCtD
Scopolamine—Dizziness—Orlistat—obesity	0.00065	0.0012	CcSEcCtD
Scopolamine—Erythema—Topiramate—obesity	0.000647	0.0012	CcSEcCtD
Scopolamine—Dizziness—Sibutramine—obesity	0.000629	0.00116	CcSEcCtD
Scopolamine—Vomiting—Orlistat—obesity	0.000625	0.00116	CcSEcCtD
Scopolamine—Rash—Orlistat—obesity	0.00062	0.00115	CcSEcCtD
Scopolamine—Dermatitis—Orlistat—obesity	0.000619	0.00114	CcSEcCtD
Scopolamine—Headache—Orlistat—obesity	0.000616	0.00114	CcSEcCtD
Scopolamine—CHRM1—cardiovascular system—obesity	0.000612	0.0485	CbGeAlD
Scopolamine—Vision blurred—Topiramate—obesity	0.00061	0.00113	CcSEcCtD
Scopolamine—Tremor—Topiramate—obesity	0.000606	0.00112	CcSEcCtD
Scopolamine—Vomiting—Sibutramine—obesity	0.000605	0.00112	CcSEcCtD
Scopolamine—Rash—Sibutramine—obesity	0.0006	0.00111	CcSEcCtD
Scopolamine—Dermatitis—Sibutramine—obesity	0.000599	0.00111	CcSEcCtD
Scopolamine—Headache—Sibutramine—obesity	0.000596	0.0011	CcSEcCtD
Scopolamine—Asthenia—Bupropion—obesity	0.000595	0.0011	CcSEcCtD
Scopolamine—Agitation—Topiramate—obesity	0.000595	0.0011	CcSEcCtD
Scopolamine—Pruritus—Bupropion—obesity	0.000587	0.00108	CcSEcCtD
Scopolamine—Nausea—Orlistat—obesity	0.000584	0.00108	CcSEcCtD
Scopolamine—Vertigo—Topiramate—obesity	0.000581	0.00108	CcSEcCtD
Scopolamine—Nausea—Sibutramine—obesity	0.000565	0.00104	CcSEcCtD
Scopolamine—Dizziness—Bupropion—obesity	0.000548	0.00101	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000547	0.00101	CcSEcCtD
Scopolamine—Dry mouth—Topiramate—obesity	0.000539	0.000997	CcSEcCtD
Scopolamine—Confusional state—Topiramate—obesity	0.000533	0.000985	CcSEcCtD
Scopolamine—Oedema—Topiramate—obesity	0.000528	0.000977	CcSEcCtD
Scopolamine—Vomiting—Bupropion—obesity	0.000527	0.000975	CcSEcCtD
Scopolamine—Rash—Bupropion—obesity	0.000523	0.000967	CcSEcCtD
Scopolamine—Dermatitis—Bupropion—obesity	0.000522	0.000966	CcSEcCtD
Scopolamine—Headache—Bupropion—obesity	0.000519	0.000961	CcSEcCtD
Scopolamine—Nervous system disorder—Topiramate—obesity	0.000518	0.000958	CcSEcCtD
Scopolamine—Tachycardia—Topiramate—obesity	0.000515	0.000953	CcSEcCtD
Scopolamine—Skin disorder—Topiramate—obesity	0.000513	0.000949	CcSEcCtD
Scopolamine—Hyperhidrosis—Topiramate—obesity	0.000511	0.000944	CcSEcCtD
Scopolamine—Hypotension—Topiramate—obesity	0.000494	0.000913	CcSEcCtD
Scopolamine—Nausea—Bupropion—obesity	0.000492	0.000911	CcSEcCtD
Scopolamine—CHRM3—adipose tissue—obesity	0.000483	0.0383	CbGeAlD
Scopolamine—Somnolence—Topiramate—obesity	0.00047	0.000868	CcSEcCtD
Scopolamine—CHRM2—endocrine gland—obesity	0.000461	0.0365	CbGeAlD
Scopolamine—Fatigue—Topiramate—obesity	0.000455	0.000842	CcSEcCtD
Scopolamine—CHRM3—digestive system—obesity	0.000455	0.036	CbGeAlD
Scopolamine—Constipation—Topiramate—obesity	0.000452	0.000835	CcSEcCtD
Scopolamine—Pain—Topiramate—obesity	0.000452	0.000835	CcSEcCtD
Scopolamine—Feeling abnormal—Topiramate—obesity	0.000435	0.000805	CcSEcCtD
Scopolamine—CHRM1—endocrine gland—obesity	0.00042	0.0333	CbGeAlD
Scopolamine—Abdominal pain—Topiramate—obesity	0.000418	0.000772	CcSEcCtD
Scopolamine—Body temperature increased—Topiramate—obesity	0.000418	0.000772	CcSEcCtD
Scopolamine—Asthenia—Topiramate—obesity	0.000379	0.000701	CcSEcCtD
Scopolamine—CHRM3—endocrine gland—obesity	0.000376	0.0298	CbGeAlD
Scopolamine—Pruritus—Topiramate—obesity	0.000374	0.000691	CcSEcCtD
Scopolamine—Dizziness—Topiramate—obesity	0.000349	0.000646	CcSEcCtD
Scopolamine—Vomiting—Topiramate—obesity	0.000336	0.000621	CcSEcCtD
Scopolamine—Rash—Topiramate—obesity	0.000333	0.000616	CcSEcCtD
Scopolamine—Dermatitis—Topiramate—obesity	0.000333	0.000615	CcSEcCtD
Scopolamine—Headache—Topiramate—obesity	0.000331	0.000612	CcSEcCtD
Scopolamine—Nausea—Topiramate—obesity	0.000314	0.00058	CcSEcCtD
Scopolamine—ABCB1—islet of Langerhans—obesity	0.000295	0.0233	CbGeAlD
Scopolamine—ABCB1—respiratory system—obesity	0.000278	0.022	CbGeAlD
Scopolamine—ABCB1—adrenal cortex—obesity	0.000233	0.0185	CbGeAlD
Scopolamine—ABCB1—cardiovascular system—obesity	0.000213	0.0169	CbGeAlD
Scopolamine—ABCB1—pituitary gland—obesity	0.000189	0.0149	CbGeAlD
Scopolamine—ABCB1—adipose tissue—obesity	0.000188	0.0149	CbGeAlD
Scopolamine—ABCB1—digestive system—obesity	0.000177	0.014	CbGeAlD
Scopolamine—ABCB1—adrenal gland—obesity	0.000169	0.0133	CbGeAlD
Scopolamine—ABCB1—endocrine gland—obesity	0.000146	0.0116	CbGeAlD
Scopolamine—ABCB1—liver—obesity	0.000132	0.0104	CbGeAlD
Scopolamine—CHRM3—Signaling by GPCR—PIK3R1—obesity	2e-05	4.59e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—FASN—obesity	2e-05	4.58e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GNAS—obesity	1.99e-05	4.57e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—BCHE—obesity	1.99e-05	4.56e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARA—obesity	1.99e-05	4.56e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3R1—obesity	1.98e-05	4.54e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOB—obesity	1.98e-05	4.53e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCL2—obesity	1.97e-05	4.52e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOB—obesity	1.97e-05	4.52e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOB—obesity	1.95e-05	4.47e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IGF1—obesity	1.94e-05	4.44e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AKT2—obesity	1.94e-05	4.44e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—POMC—obesity	1.93e-05	4.43e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL5—obesity	1.93e-05	4.43e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AGT—obesity	1.92e-05	4.41e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL5—obesity	1.92e-05	4.41e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—INS—obesity	1.92e-05	4.4e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP2E1—obesity	1.92e-05	4.4e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL5—obesity	1.9e-05	4.37e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NQO1—obesity	1.9e-05	4.35e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCL2—obesity	1.89e-05	4.33e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LPL—obesity	1.89e-05	4.33e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOE—obesity	1.89e-05	4.32e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LPL—obesity	1.88e-05	4.31e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—FOXO1—obesity	1.87e-05	4.3e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RPS6KB1—obesity	1.87e-05	4.29e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CAV1—obesity	1.87e-05	4.28e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—FOXO1—obesity	1.87e-05	4.28e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RPS6KB1—obesity	1.86e-05	4.27e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOA1—obesity	1.86e-05	4.27e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LPL—obesity	1.86e-05	4.27e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CD—obesity	1.86e-05	4.27e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IGF1—obesity	1.86e-05	4.26e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AKT2—obesity	1.85e-05	4.25e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CB—obesity	1.85e-05	4.25e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—FOXO1—obesity	1.85e-05	4.24e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RPS6KB1—obesity	1.85e-05	4.23e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CB—obesity	1.85e-05	4.23e-05	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—PIK3CA—obesity	1.84e-05	4.23e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SERPINE1—obesity	1.84e-05	4.22e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CB—obesity	1.83e-05	4.19e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SLC2A4—obesity	1.82e-05	4.17e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GCG—obesity	1.82e-05	4.17e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYCS—obesity	1.8e-05	4.12e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TYK2—obesity	1.79e-05	4.11e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CD—obesity	1.78e-05	4.09e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—RHOA—obesity	1.78e-05	4.07e-05	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—PIK3CA—obesity	1.77e-05	4.05e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SERPINE1—obesity	1.76e-05	4.04e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GGT1—obesity	1.76e-05	4.04e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GOT1—obesity	1.76e-05	4.04e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3R1—obesity	1.76e-05	4.03e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NOS3—obesity	1.76e-05	4.03e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PRKCD—obesity	1.74e-05	3.99e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NCOA1—obesity	1.74e-05	3.98e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PRKCD—obesity	1.73e-05	3.97e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PRKCD—obesity	1.72e-05	3.94e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TYK2—obesity	1.71e-05	3.93e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CYP19A1—obesity	1.71e-05	3.92e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—STK11—obesity	1.71e-05	3.92e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CG—obesity	1.7e-05	3.9e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HTR2A—obesity	1.7e-05	3.9e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—RHOA—obesity	1.7e-05	3.9e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—C3—obesity	1.7e-05	3.9e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HTR2A—obesity	1.7e-05	3.89e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—C3—obesity	1.69e-05	3.88e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3R1—obesity	1.68e-05	3.86e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NOS3—obesity	1.68e-05	3.86e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HTR2A—obesity	1.68e-05	3.85e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—C3—obesity	1.68e-05	3.85e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PIK3CA—obesity	1.67e-05	3.84e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARG—obesity	1.64e-05	3.77e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CB—obesity	1.62e-05	3.72e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MTOR—obesity	1.62e-05	3.72e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—POMC—obesity	1.62e-05	3.71e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IRS2—obesity	1.62e-05	3.71e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AGT—obesity	1.61e-05	3.7e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IRS2—obesity	1.61e-05	3.69e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—INS—obesity	1.61e-05	3.69e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AGT—obesity	1.61e-05	3.69e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PIK3CA—obesity	1.6e-05	3.68e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IRS2—obesity	1.6e-05	3.66e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AGT—obesity	1.59e-05	3.65e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—COMT—obesity	1.59e-05	3.65e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—LEP—obesity	1.58e-05	3.63e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOE—obesity	1.58e-05	3.63e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOE—obesity	1.58e-05	3.62e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—LEP—obesity	1.58e-05	3.62e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GNB3—obesity	1.57e-05	3.6e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARGC1A—obesity	1.57e-05	3.6e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CAV1—obesity	1.57e-05	3.59e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOA1—obesity	1.56e-05	3.59e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CAV1—obesity	1.56e-05	3.58e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—LEP—obesity	1.56e-05	3.58e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOE—obesity	1.56e-05	3.58e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HMOX1—obesity	1.56e-05	3.58e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOA1—obesity	1.56e-05	3.57e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MTOR—obesity	1.55e-05	3.56e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CB—obesity	1.55e-05	3.56e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CAV1—obesity	1.55e-05	3.55e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOA1—obesity	1.54e-05	3.54e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GNAS—obesity	1.53e-05	3.5e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ESR1—obesity	1.51e-05	3.46e-05	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AKT1—obesity	1.51e-05	3.45e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ESR1—obesity	1.51e-05	3.45e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CD—obesity	1.5e-05	3.43e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOB—obesity	1.49e-05	3.43e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—F2—obesity	1.49e-05	3.42e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PRKCB—obesity	1.49e-05	3.42e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ESR1—obesity	1.49e-05	3.42e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—F2—obesity	1.49e-05	3.41e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PRKCB—obesity	1.49e-05	3.41e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—IL6—obesity	1.48e-05	3.4e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ALB—obesity	1.48e-05	3.39e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—BAD—obesity	1.47e-05	3.38e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—F2—obesity	1.47e-05	3.38e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PRKCB—obesity	1.47e-05	3.38e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—BAD—obesity	1.47e-05	3.37e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—BAD—obesity	1.45e-05	3.34e-05	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AKT1—obesity	1.44e-05	3.31e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CG—obesity	1.43e-05	3.27e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—LPL—obesity	1.43e-05	3.27e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CG—obesity	1.42e-05	3.26e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—IL6—obesity	1.42e-05	3.26e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3R1—obesity	1.41e-05	3.24e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—NOS3—obesity	1.41e-05	3.24e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IRS1—obesity	1.41e-05	3.24e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MMP9—obesity	1.41e-05	3.23e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CG—obesity	1.41e-05	3.23e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IRS1—obesity	1.41e-05	3.23e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IRS1—obesity	1.39e-05	3.19e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GPX1—obesity	1.39e-05	3.19e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MAPK8—obesity	1.37e-05	3.14e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AKT1—obesity	1.37e-05	3.14e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—POMC—obesity	1.36e-05	3.12e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CD36—obesity	1.36e-05	3.11e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—POMC—obesity	1.35e-05	3.11e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—INS—obesity	1.35e-05	3.1e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MMP9—obesity	1.35e-05	3.1e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—INS—obesity	1.35e-05	3.09e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—POMC—obesity	1.34e-05	3.08e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—INS—obesity	1.33e-05	3.06e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCL2—obesity	1.33e-05	3.05e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCL2—obesity	1.33e-05	3.04e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MAPK8—obesity	1.31e-05	3.01e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCL2—obesity	1.31e-05	3.01e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AKT1—obesity	1.31e-05	3e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF1—obesity	1.31e-05	3e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKT2—obesity	1.31e-05	2.99e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CB—obesity	1.3e-05	2.99e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF1—obesity	1.3e-05	2.99e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKT2—obesity	1.3e-05	2.99e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTGS2—obesity	1.29e-05	2.96e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF1—obesity	1.29e-05	2.96e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKT2—obesity	1.29e-05	2.96e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MTHFR—obesity	1.29e-05	2.95e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARA—obesity	1.26e-05	2.89e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CD—obesity	1.25e-05	2.88e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—STAT3—obesity	1.25e-05	2.87e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CD—obesity	1.25e-05	2.87e-05	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PIK3CA—obesity	1.24e-05	2.85e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SERPINE1—obesity	1.24e-05	2.85e-05	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PIK3CA—obesity	1.24e-05	2.84e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CD—obesity	1.24e-05	2.84e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SERPINE1—obesity	1.24e-05	2.84e-05	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PIK3CA—obesity	1.23e-05	2.81e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SERPINE1—obesity	1.23e-05	2.81e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AGT—obesity	1.22e-05	2.8e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TYK2—obesity	1.21e-05	2.77e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TYK2—obesity	1.2e-05	2.76e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—STAT3—obesity	1.2e-05	2.75e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—RHOA—obesity	1.2e-05	2.75e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOE—obesity	1.2e-05	2.74e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—RHOA—obesity	1.19e-05	2.74e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TYK2—obesity	1.19e-05	2.73e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CAV1—obesity	1.19e-05	2.72e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3R1—obesity	1.18e-05	2.72e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NOS3—obesity	1.18e-05	2.72e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOA1—obesity	1.18e-05	2.71e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—RHOA—obesity	1.18e-05	2.71e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3R1—obesity	1.18e-05	2.71e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NOS3—obesity	1.18e-05	2.71e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3R1—obesity	1.17e-05	2.68e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NOS3—obesity	1.17e-05	2.68e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MYC—obesity	1.16e-05	2.67e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TGFB1—obesity	1.16e-05	2.66e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CA—obesity	1.13e-05	2.59e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CA—obesity	1.13e-05	2.58e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MYC—obesity	1.12e-05	2.56e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CA—obesity	1.11e-05	2.56e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TGFB1—obesity	1.11e-05	2.55e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MTOR—obesity	1.09e-05	2.51e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CB—obesity	1.09e-05	2.51e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MTOR—obesity	1.09e-05	2.5e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CB—obesity	1.09e-05	2.5e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CG—obesity	1.08e-05	2.48e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MTOR—obesity	1.08e-05	2.48e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CB—obesity	1.08e-05	2.48e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARG—obesity	1.04e-05	2.39e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—POMC—obesity	1.03e-05	2.36e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—INS—obesity	1.02e-05	2.34e-05	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AKT1—obesity	1.02e-05	2.33e-05	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AKT1—obesity	1.01e-05	2.32e-05	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AKT1—obesity	1e-05	2.3e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—IL6—obesity	9.99e-06	2.29e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—IL6—obesity	9.96e-06	2.28e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CA—obesity	9.89e-06	2.27e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—IL6—obesity	9.87e-06	2.26e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MMP9—obesity	9.51e-06	2.18e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CD—obesity	9.49e-06	2.18e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MMP9—obesity	9.48e-06	2.17e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CA—obesity	9.47e-06	2.17e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MMP9—obesity	9.38e-06	2.15e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—ALB—obesity	9.37e-06	2.15e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MAPK8—obesity	9.25e-06	2.12e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AKT1—obesity	9.22e-06	2.11e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MAPK8—obesity	9.22e-06	2.11e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AKT1—obesity	9.19e-06	2.11e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MAPK8—obesity	9.13e-06	2.09e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AKT1—obesity	9.1e-06	2.09e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3R1—obesity	8.96e-06	2.06e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NOS3—obesity	8.96e-06	2.06e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IL6—obesity	8.76e-06	2.01e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—STAT3—obesity	8.45e-06	1.94e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—STAT3—obesity	8.43e-06	1.93e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IL6—obesity	8.39e-06	1.92e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—STAT3—obesity	8.34e-06	1.91e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CB—obesity	8.27e-06	1.9e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTGS2—obesity	8.2e-06	1.88e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AKT1—obesity	8.08e-06	1.85e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CA—obesity	7.95e-06	1.82e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MYC—obesity	7.85e-06	1.8e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TGFB1—obesity	7.84e-06	1.8e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MYC—obesity	7.83e-06	1.8e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TGFB1—obesity	7.81e-06	1.79e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MYC—obesity	7.75e-06	1.78e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AKT1—obesity	7.74e-06	1.77e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TGFB1—obesity	7.73e-06	1.77e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CA—obesity	6.67e-06	1.53e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CA—obesity	6.65e-06	1.52e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CA—obesity	6.58e-06	1.51e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AKT1—obesity	6.49e-06	1.49e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IL6—obesity	5.9e-06	1.35e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IL6—obesity	5.89e-06	1.35e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IL6—obesity	5.83e-06	1.34e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKT1—obesity	5.45e-06	1.25e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKT1—obesity	5.43e-06	1.25e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKT1—obesity	5.38e-06	1.23e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CA—obesity	5.04e-06	1.16e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AKT1—obesity	4.12e-06	9.45e-06	CbGpPWpGaD
